AJ Joshi, MD

Articles by AJ Joshi, MD

Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MD

February 17th 2022

The chief medical officer at Atara Biotherapeutics provided insight on the future direction of its investigational agent ATA188 following new data that suggested a link between Epstein-Barr virus and multiple sclerosis. [WATCH TIME: 4 minutes]

ATA188, Targeting EBV Antigens to Treat Progressive MS: AJ Joshi, MD

ByAJ Joshi, MD

February 11th 2022

The chief medical officer at Atara Biotherapeutics discussed the investigational agent ATA188, its mechanism to treat multiple sclerosis, and what to look for in its upcoming EMBOLD trial data readout. [WATCH TIME: 4 minutes]

Understanding the Epidemiological Connection Between MS and Epstein-Barr Virus: AJ Joshi, MD

ByAJ Joshi, MD

February 9th 2022

The chief medical officer at Atara Biotherapeutics detailed the clinical significance of a recently published paper in Nature that adds to the evidence that Epstein-Barr virus is the leading cause of multiple sclerosis. [WATCH TIME: 3 minutes]

AJ Joshi, MD

Articles by AJ Joshi, MD

Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MD

ATA188, Targeting EBV Antigens to Treat Progressive MS: AJ Joshi, MD

Understanding the Epidemiological Connection Between MS and Epstein-Barr Virus: AJ Joshi, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential

Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms

Incorporating AI Into Stroke Triage

NeuroVoices: Gerald Maguire, MD, on Raising Awareness of the Neurobiology of Stuttering

Trappsol Cyclo Shows Promising Results in Newborns With Niemann Pick Disease Type C1